Genomma Lab InternacionalB de CV (MEX:LABB) Net Change in Cash: MXN-153 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:LABB Genomma Lab Internacional SAB de CV MEX:LABB
66 GF Score
Price MXN14.67
GF Value MXN17.26
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV Net Change in Cash?

Genomma Lab InternacionalB de CV MEX:LABB +1.17% 66 Net Change in Cash is MXN-153 Mil as of Jun. 2026. GuruFocus rates MEX:LABB with a GF Score™ of 66/100 and a GF Value™ of MXN17.26 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Genomma Lab InternacionalB de CV's Net Change in Cash for the three months ended in Jun. 2026 was MXN-374 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-153 Mil.

Genomma Lab InternacionalB de CV Net Change in Cash Related Terms

Genomma Lab InternacionalB de CV Net Change in Cash Historical Data

* Premium members only.

The historical data trend for Genomma Lab InternacionalB de CV's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV Net Change in Cash Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -839.04 33.11 190.39 801.53 569.68

Genomma Lab InternacionalB de CV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 430.86 -192.33 677.61 -264.13 -373.92
MEX:LABB
66GF Score
Genomma Lab Internacional SAB de CV MEX:LABB
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV Net Change in Cash Calculation

Genomma Lab InternacionalB de CV's Net Change in Cash for the fiscal year that ended in Dec. 2025 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=2054.536+-752.799+-475.397+-256.657
=570

Genomma Lab InternacionalB de CV's Net Change in Cash for the quarter that ended in Jun. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=383.158+-119.682+-672.85+35.453
=-374

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-153 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of MXN-153 Mil mean?
Genomma Lab InternacionalB de CV (MEX:LABB) has a Net Change in Cash of MXN-153 Mil as of Jun. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Genomma Lab InternacionalB de CV and its competitors.
Is Genomma Lab InternacionalB de CV's Net Change in Cash too high?
Genomma Lab InternacionalB de CV's current Net Change in Cash is MXN-153 Mil. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Net Change in Cash compare to ZTS and UTHR?
Genomma Lab InternacionalB de CV's Net Change in Cash of MXN-153 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Drug Manufacturers company?
A good Net Change in Cash depends on the Drug Manufacturers industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Genomma Lab InternacionalB de CV and its competitors. Genomma Lab InternacionalB de CV's current Net Change in Cash is MXN-153 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.26, compared to a current price of MXN14.67 — trading 15% below its estimated fair value. The current Net Change in Cash is MXN-153 Mil. Genomma Lab InternacionalB de CV's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Net Change in Cash is MXN-153 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of MXN14.67 is trading 15% below its estimated GF Value™ of MXN17.26. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for MEX:LABB:

  • Net Change in Cash: MXN-153 Mil
  • GF Value™: MXN17.26 vs. price of MXN14.67 (15% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomma Lab InternacionalB de CV Business Description

Other Exchanges GNMLF:USAGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
66GF Score

Get the complete analysis for MEX:LABB

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN14.67
Price
MXN17.26
GF Value